107 related articles for article (PubMed ID: 2882023)
1. Electrocortical spectrum power effects of different classes of neuroleptics in rats.
Bagetta G; Corasaniti MT; Strongoli MC; Sakurada S; Nisticò G
J Psychiatr Res; 1987; 21(1):93-9. PubMed ID: 2882023
[TBL] [Abstract][Full Text] [Related]
2. Ventral tegmental area: site through which dopamine D2-receptor agonists evoke behavioural and electrocortical sleep in rats.
Bagetta G; De Sarro G; Priolo E; Nisticò G
Br J Pharmacol; 1988 Nov; 95(3):860-6. PubMed ID: 2974741
[TBL] [Abstract][Full Text] [Related]
3. Behavioural and ECoG spectrum power effects after intraventricular injection of drugs altering dopaminergic transmission in rats.
Bagetta G; Corasaniti MT; Strongoli MC; Sakurada S; Nisticò G
Neuropharmacology; 1987 Aug; 26(8):1047-52. PubMed ID: 2889160
[TBL] [Abstract][Full Text] [Related]
4. Evidence that locus coeruleus is the site where clonidine and drugs acting at alpha 1- and alpha 2-adrenoceptors affect sleep and arousal mechanisms.
De Sarro GB; Ascioti C; Froio F; Libri V; Nisticò G
Br J Pharmacol; 1987 Apr; 90(4):675-85. PubMed ID: 2884006
[TBL] [Abstract][Full Text] [Related]
5. Different profile of electrocortical power spectrum changes after micro-infusion into the locus coeruleus of selective agonists at various opioid receptor subtypes in rats.
Bagetta G; De Sarro GB; Sakurada S; Rispoli V; Nisticò G
Br J Pharmacol; 1990 Nov; 101(3):655-61. PubMed ID: 1963804
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment with chlorpromazine and haloperidol but not with sulpiride and clozapine markedly elevates neuropeptide Y-like immunoreactivity in the rat hypothalamus.
Obuchowicz E
Neuropeptides; 1996 Oct; 30(5):471-8. PubMed ID: 8923510
[TBL] [Abstract][Full Text] [Related]
7. Effects of some antipsychotic drugs on cardiovascular catecholamine receptors in the rat.
Cuffí ML; Vila E; Badia A
J Auton Pharmacol; 1989 Dec; 9(6):397-409. PubMed ID: 2576023
[TBL] [Abstract][Full Text] [Related]
8. Behavioural and electrocortical changes induced by muscimol in rats withdrawn from chronic treatment with diazepam.
Bagetta G; Sakurada S; Corasaniti MT; Froio F; Nisticò G
Neuropharmacology; 1987 Jul; 26(7A):725-30. PubMed ID: 3627381
[TBL] [Abstract][Full Text] [Related]
9. Effects of dopamine D-1 and D-2 antagonists on decision making by rats: no reversal of neuroleptic-induced attenuation by scopolamine.
Ljungberg T; Enquist M
J Neural Transm Gen Sect; 1990; 82(3):167-79. PubMed ID: 1979001
[TBL] [Abstract][Full Text] [Related]
10. Naloxone antagonizes behavioural and ECoG effects induced by systemic or intracerebral administration of some lymphokines.
De Sarro GB; Nisticò G
Ann Ist Super Sanita; 1990; 26(1):99-106. PubMed ID: 2393221
[TBL] [Abstract][Full Text] [Related]
11. Differential behavioural effect of quinpirole in neuroleptic-pretreated rats - role of alpha(1)-adrenoceptor.
Obuchowicz E
Eur J Pharmacol; 1999 Nov; 384(2-3):101-9. PubMed ID: 10611430
[TBL] [Abstract][Full Text] [Related]
12. Microinfusion of clonidine and yohimbine into locus coeruleus alters EEG power spectrum: effects of aging and reversal by phosphatidylserine.
de Sarro GB; Bagetta G; Ascioti C; Libri V; Nisticò G
Br J Pharmacol; 1988 Dec; 95(4):1278-86. PubMed ID: 2851361
[TBL] [Abstract][Full Text] [Related]
13. Evidence that behavioural and electrocortical sleep induced by guanfacine is due to stimulation of alpha 2-adrenoceptors.
Rotiroti D; Silvestri R; de Sarro GB; Bagetta G; Nisticò G
J Psychiatr Res; 1982-1983; 17(3):231-9. PubMed ID: 6317857
[TBL] [Abstract][Full Text] [Related]
14. Dopamine receptor blocking activity of sulpiride in the central nervous system.
Honda F; Satoh Y; Shimomura K; Satoh H; Noguchi H; Uchida S; Kato R
Jpn J Pharmacol; 1977 Jun; 27(3):397-411. PubMed ID: 562433
[TBL] [Abstract][Full Text] [Related]
15. Atypical neuroleptics increase self-administration of cocaine: an evaluation of a behavioural screen for antipsychotic activity.
Roberts DC; Vickers G
Psychopharmacology (Berl); 1984; 82(1-2):135-9. PubMed ID: 6141584
[TBL] [Abstract][Full Text] [Related]
16. [The inhibition of dopamine D1 and D2 receptors in human putamen by antipsychotic drugs].
Kobayashi T; Shimizu H; Toru M
Yakubutsu Seishin Kodo; 1990 Jun; 10(2):331-4. PubMed ID: 1979198
[TBL] [Abstract][Full Text] [Related]
17. Effects of haloperidol and chlorpromazine on smooth muscle contractility, platelet aggregation and neuronal calcium current.
Prokopenko RA; Mogilevich SE; Luik AI; Naydyenova IY; Batrak GN; Hawryluk BR; Degtiar VY
Gen Physiol Biophys; 1995 Aug; 14(4):349-57. PubMed ID: 8720698
[TBL] [Abstract][Full Text] [Related]
18. Influence of neuroleptics on cytotoxic activity of macrophages in rats.
Madej A; Belowski D; Kowalski J; Herman ZS
Boll Chim Farm; 1998 May; 137(5):135-9. PubMed ID: 9689898
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic properties of cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-09151-2) with selective antidopaminergic activity.
Usuda S; Nishikori K; Noshiro O; Maeno H
Psychopharmacology (Berl); 1981; 73(2):103-9. PubMed ID: 6112770
[TBL] [Abstract][Full Text] [Related]
20. Sulpiride: assessment of a pharmacologically and chemically distinct neuroleptic.
Rich TD
Med Hypotheses; 1984 May; 14(1):69-81. PubMed ID: 6146915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
